No abstract

Abnormal vaginal discharge is one of the frequent complaints of women of reproductive age group. This study was carried out to determine the prevalence of vulvovaginal candidiasis(VVC) among the patients attending the tertiary care hospital with complaints of suggestive of vaginitis. This study was done in a tertiary care hospital, Chennai for a period of 1 year from January 2017 to December 2017. The study included 160 women of the age group 15 -65 years with complaints suggestive of vaginitis. High vaginal swabs were taken and subjected to direct microscopy, cultured onto Sabouraud Dextrose Agar (SDA) and Hichrome Candida differential agar. Candida species were determined by standard microbiological methods and the results were confirmed by automated VITEK2 compact. Candida species were isolated from 56 patients which included C.albicans (25), C.tropicalis (20), C.glabrata (6), C.parapsilosis(4), C.krusei(1). Our study shows higher prevalence of non albicans Candida causing VVC. Hence, we recommend that the investigations up to species identification of Candida may be routinely followed in the microbiology laboratories.

We conclude that SG can be blocked effectively and safely through the lateral approach at the C6 level under ultrasonogram and fluoroscopic guidance.

No abstract

Background: To evaluate the adequacy of combined psoas and sacral plexus block (SPB) as a sole anesthetic agent, patients'/ surgeons' satisfaction, perioperative urinary retention, and duration of postoperative analgesia for unilateral lower limb surgeries.

No abstract

No abstract

Methicillin-resistant Staphylococcus aureus (MRSA) adds a significant burden for health-care workers. In India there is a significant rise in prevalence of Methicillin resistant Staphylococcus aureus recently. Treatment has become very difficult among the resistant Staphylococcal isolates. Currently vancomycin and linezolid are the commonly used antibiotics. But these drugs have their adverse effects. Hence improved bactericidal antibiotics with increased tissue penetration and low possibility of developing resistance and safe to be used in chronic cases should be used for management of Methicillin resistant Staphylococcus aureus infections. The drug Levonadifloxacin acts actively against Methicillin resistant Staphylococcus aureus and Quinolone - resistant Staphylococcus aureus phenotypes. Recently in India, levonadifloxacin has been approved for the treatment of various infections like acute bacterial skin and soft tissue infections with complicating blood stream infections and also for diabetes complicating infections. Hence we evaluated the activity of levonadifloxacin (10g) by Kirby– Bauer disk diffusion assay against Methicillin resistant Staphylococcus aureus isolates in the central laboratory of a tertiary care centre for a period of 1year between May 2021 to April 2022. 296 isolates of Staphylococcus aureus were identified from various clinical samples. Based on the results of disc diffusion test using Cefoxitin disc, Of the 296 Staphylococcus aureus isolates 104 were methicillin resistant and the rest of the 192 were methicillin sensitive. Methicillin resistant Staphylococcus aureus isolates were tested against levonadifloxacin by disc diffusion which yielded 100% susceptibility rate. Hence this study displays potent activity of the drug levonadifloxacin against Methicillin resistant Staphylococcus aureus isolates and is recommended for therapeutic use.